InsiderTrades

Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.

Accepted 2021-07-14 00:00:00 ET · period of report 2021-07-12 · accession 0001735276-21-000053 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-07-14 2021-07-12 ALNY KEATING LAURIE EVP, CLO M - OptEx $87.90 +6,812 11.9K +133% +$598.8K
DM 2021-07-14 2021-07-12 ALNY KEATING LAURIE EVP, CLO S - Sale+OE $178.96 -6,812 10.1K -40% -$1.22M
DM 2021-07-14 2021-07-12 ALNY KEATING LAURIE EVP, CLO M - OptEx $0.00 -6,812 17.2K -28% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-12 M A 1,812 $85.00 6,944 D — —
2 Common Common Stock 2021-07-12 S D 5,000 $178.95 5,132 D — —
3 Common Common Stock 2021-07-12 S D 1,812 $179.00 10,132 D — —
4 Common Common Stock 2021-07-12 M A 5,000 $88.95 11,944 D — —
5 Derivative Stock Option (right to buy) 2021-07-12 M D 5,000 $0.00 9,000 D $88.95 · — to 2025-12-18 5,000 Common Stock (F3) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
6 Derivative Stock Option (right to buy) 2021-07-12 M D 1,812 $0.00 17,188 D $85.00 · — to 2029-02-27 1,812 Common Stock (F3) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.